|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - KalVista Pharmaceuticals Inc. (KALV)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-04-22 Sale |
2019-04-23 5:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,355 | $26.04 | $191,530 | 102,100 (Direct) |
View |
| 2019-04-15 Sale |
2019-04-23 5:30 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $24.8 | $247,958 | 258,810 (Direct) |
View |
| 2019-04-18 Sale |
2019-04-22 5:58 pm |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
3,073 | $25.7 | $78,976 | 59,611 (Direct) |
View |
| 2019-04-17 Sale |
2019-04-18 6:30 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
4,000 | $24.92 | $99,666 | 100,950 (Direct) |
View |
| 2019-04-08 Sale |
2019-04-10 7:21 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
50,000 | $29.2 | $1,460,145 | 1,698,554 (Direct) |
View |
| 2019-04-05 Sale |
2019-04-09 5:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP |
5,000 | $30 | $150,011 | 60,000 (Direct) |
View |
| 2019-03-29 Sale |
2019-04-02 6:57 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
97,074 | $28.03 | $2,720,897 | 1,780,986 (Direct) |
View |
| 2019-03-26 Sale |
2019-03-28 5:29 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
124,675 | $28.84 | $3,596,032 | 1,907,090 (Direct) |
View |
| 2019-03-18 Sale |
2019-03-20 4:13 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
262,470 | $26.7 | $7,007,949 | 1,936,352 (Direct) |
View |
| 2019-03-18 Sale |
2019-03-20 4:08 pm |
KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners II L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner |
500,000 | $28.75 | $14,375,000 | 1,544,112 (Indirect) |
View |
| 2019-03-14 Sale |
2019-03-15 8:03 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
3,000 | $30.16 | $90,484 | 268,510 (Direct) |
View |
| 2019-03-04 Sale |
2019-03-06 09:05 am |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
75,710 | $22.96 | $1,738,476 | 2,223,015 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 2:35 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
214,198 | $20.55 | $4,401,353 | 2,455,569 (Direct) |
View |
| 2019-01-25 Sale |
2019-01-29 6:53 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,453 | $17.06 | $93,015 | 109,455 (Direct) |
View |
| 2019-01-22 Sale |
2019-01-24 7:48 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,902 | $17.01 | $32,344 | 115,508 (Direct) |
View |
| 2019-01-16 Sale |
2019-01-18 5:42 pm |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
4,000 | $19.55 | $78,210 | 106,334 (Direct) |
View |
| 2019-01-14 Sale |
2019-01-16 6:25 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $19.33 | $193,328 | 272,411 (Direct) |
View |
| 2019-01-03 Sale |
2019-01-07 5:12 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
4,299 | $20.25 | $87,073 | 2,476,008 (Direct) |
View |
| 2018-12-28 Sale |
2019-01-02 7:10 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
29,352 | $20.01 | $587,242 | 2,502,571 (Direct) |
View |
| 2018-12-19 Sale |
2018-12-21 4:19 pm |
KalVista Pharmaceuticals Inc. | KALV | SVLSF IV LLC SV Life Sciences Fund IV (GP) L.P. SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L. P. SV LIFE SCIENCES FUND IV L.P. 10% Owner |
2,136 | $20.02 | $42,758 | 2,506,202 (Direct) |
View |
| 2018-09-10 Purchase |
2018-09-12 7:16 pm |
KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director |
58,824 | $17 | $1,000,008 | 388,766 (Indirect) |
View |
| 2018-09-10 Purchase |
2018-09-12 7:11 pm |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
1,058,824 | $17 | $18,000,008 | 1,359,149 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-06-26 Option Award |
2019-06-28 5:36 pm |
N/A 2019-06-25 |
KalVista Pharmaceuticals Inc. | KALV | Edwards Martin Director |
14,000 | $20.62 | 14,000 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 5:44 pm |
N/A 2029-05-14 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
33,750 | $24.23 | 33,750 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 5:34 pm |
N/A 2029-05-14 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
27,900 | $24.23 | 27,900 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 5:29 pm |
N/A 2029-05-14 |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP |
9,000 | $24.23 | 9,000 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 5:22 pm |
N/A 2029-05-14 |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
20,250 | $24.23 | 20,250 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 5:17 pm |
N/A 2029-05-14 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
67,500 | $24.23 | 67,500 (Direct) |
View |
| 2019-04-22 Exercise |
2019-04-23 5:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,355 | $0.0043 | 102,100 (Direct) |
View |
| 2019-04-22 Exercise |
2019-04-23 5:33 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,355 | $0.0043 | 102,100 (Direct) |
View |
| 2019-04-22 Option Award |
2019-04-23 5:29 pm |
N/A 2029-04-21 |
KalVista Pharmaceuticals Inc. | KALV | SOLAND DANIEL B Director |
14,000 | $26.4 | 14,000 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 5:58 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
1,073 | $6.74 | 59,611 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 5:58 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
2,000 | $8.39 | 59,611 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 5:58 pm |
N/A 2026-12-28 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
1,073 | $6.74 | 59,611 (Direct) |
View |
| 2019-04-18 Exercise |
2019-04-22 5:58 pm |
N/A 2026-11-21 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
2,000 | $8.39 | 59,611 (Direct) |
View |
| 2019-04-05 Exercise |
2019-04-09 5:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP |
5,000 | $7.91 | 60,000 (Direct) |
View |
| 2019-04-05 Exercise |
2019-04-09 5:33 pm |
N/A 2027-03-07 |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP |
5,000 | $7.91 | 60,000 (Direct) |
View |
| 2019-02-01 Option Award |
2019-02-05 5:41 pm |
N/A 2029-01-31 |
KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director |
14,000 | $17.95 | 14,000 (Direct) |
View |
| 2019-01-25 Exercise |
2019-01-29 6:53 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,453 | $0.0043 | 109,455 (Direct) |
View |
| 2019-01-25 Exercise |
2019-01-29 6:53 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,453 | $0.0043 | 109,455 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,302 | $0.0043 | 115,508 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
600 | $0.0043 | 115,508 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,302 | $0.0043 | 115,508 (Direct) |
View |
| 2019-01-22 Exercise |
2019-01-24 7:48 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
600 | $0.0043 | 115,508 (Direct) |
View |
| 2016-11-21 Option Award |
2019-01-24 7:44 pm |
N/A 2026-03-30 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
116,810 | $0.0043 | 116,810 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:08 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:07 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | ORONSKY ARNOLD L Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:05 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | Cha Albert Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-10-03 Option Award |
2018-10-05 6:03 pm |
N/A 2028-10-02 |
KalVista Pharmaceuticals Inc. | KALV | ALDRICH RICHARD Director |
7,000 | $22.65 | 7,000 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:35 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Maetzel Andreas VP |
20,700 | $16.08 | 20,700 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
12,500 | $0 | 110,534 (Direct) |
View |
| 2018-09-18 Tax Withholding |
2018-09-20 7:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
2,500 | $17.05 | 110,534 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:33 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Feener Edward P. Chief Scientific Officer |
52,600 | $16.08 | 110,534 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:31 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
52,600 | $16.08 | 52,600 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:29 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
32,500 | $0 | 52,600 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:29 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CFO |
52,600 | $16.08 | 52,600 (Direct) |
View |
| 2018-09-18 Option Award |
2018-09-20 7:26 pm |
N/A 2028-09-17 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
150,000 | $16.08 | 150,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 17 Jul 2019 17:41:51 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |